ESC-Leitlinien 2021 zur Schrittmacher- und Resynchronisationstherapie: Was gibt es Neues?

Translated title of the contribution: ESC guidelines 2021 on cardiac pacing and cardiac resynchronization therapy: What’s new?

Julia Vogler, Ahmad Keelani, Anna Traub, Roland Richard Tilz*

*Corresponding author for this work
3 Citations (Scopus)

Abstract

The new European Society of Cardiology (ESC) guidelines on cardiac pacing and cardiac resynchronization therapy were presented together with the new ESC heart failure guidelines at the ESC congress in September. The new document includes detailed sections on patient evaluation and clinical assessment, implantation, minimizing complications and patient follow-up. The guidelines have been updated and expanded particularly on the approach to reflex syncope, the indications after transcatheter aortic valve implantation (TAVI) and the perioperative management. The indications for cardiac resynchronization therapy (CRT) are now in line with the simultaneously published ESC heart failure guidelines. New physiological forms of stimulation and leadless pacing are now included in the guidelines.

Translated title of the contributionESC guidelines 2021 on cardiac pacing and cardiac resynchronization therapy: What’s new?
Original languageGerman
JournalHerz
Volume47
Issue number1
Pages (from-to)31-40
Number of pages10
ISSN0340-9937
DOIs
Publication statusPublished - 02.2022

Research Areas and Centers

  • Centers: Cardiological Center Luebeck (UHZL)

DFG Research Classification Scheme

  • 205-12 Cardiology, Angiology

Cite this